COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
Expansion Therapeutics develops oral small‑molecule drugs that bind structured, disease‑driving RNA using its SMiRNA platform, integrating patient genetics, informatics, RNA‑focused screening, and structural biology toward neurodegenerative and expansion‑repeat indications.
